Cyclic phosphatidic acid - a unique bioactive phospholipid.
about
Structural evidence of the species-dependent albumin binding of the modified cyclic phosphatidic acid with cytotoxic propertiesAntinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain.Cellular function and molecular structure of ecto-nucleotidases.Cyclic phosphatidic acid relieves osteoarthritis symptoms.Lysophosphatidic acid in atherosclerotic diseasesAiming drug discovery at lysophosphatidic acid targets.Phospholipase D toxins of brown spider venom convert lysophosphatidylcholine and sphingomyelin to cyclic phosphatesProtection of neuroblastoma Neuro2A cells from hypoxia-induced apoptosis by cyclic phosphatidic acid (cPA).Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acidCyclic phosphatidic acid stimulates cAMP production and inhibits growth in human colon cancer cells.PPAR γ Networks in Cell Signaling: Update and Impact of Cyclic Phosphatidic Acid.Autotaxin: its role in biology of melanoma cells and as a pharmacological target.Nuclear sphingolipid metabolism.Blocking the peroxisome proliferator-activated receptor (PPAR): an overview.Release of cyclic phosphatidic acid from gelatin-based hydrogels inhibit colon cancer cell growth and migration.The glycerophospholipid inventory of Pseudomonas putida is conserved between strains and enables growth condition-related alterations.The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists.Lysophosphatidic Acid Stimulates MCP-1 Secretion from C2C12 Myoblast.Lysophospholipid-Related Diseases and PPARγ Signaling Pathway.Age-related changes in cyclic phosphatidic acid-induced hyaluronic acid synthesis in human fibroblasts.Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach.Lipidomic analysis of immune activation in equine leptospirosis and Leptospira-vaccinated horses.Development and application of a UHPLC-MS/MS metabolomics based comprehensive systemic and tissue-specific screening method for inflammatory, oxidative and nitrosative stress.2-carba cyclic phosphatidic acid suppresses inflammation via regulation of microglial polarisation in the stab-wounded mouse cerebral cortex.
P2860
Q27704759-28D19D81-F990-45AE-A5EB-74993B272339Q30501034-09B1E661-2701-4B27-85FB-B9789F1173C8Q34031794-EF2EDD94-6593-4ED7-B157-AEEE6F0AB6A1Q34078519-600D95CD-E5BD-481F-9EC4-5C9E108B1369Q34273486-A7143AED-B69C-4CD6-8F06-A301ECC2D89CQ34339759-20D2550A-93D1-4EEC-BFF1-BA29D1E88ED3Q34369031-8E8FAA78-2DDE-4FD5-8287-56A72B9F20DEQ34516098-315F11BB-8FC7-4DCF-ACFF-066729E795BCQ34580111-2F508977-FF34-46BA-AE13-C0C101375DDAQ35055216-FB2B1701-8D9A-42A8-8248-D1F8770CB93FQ36637912-EC16D0EA-9A7D-4411-B390-1DA47B2D9876Q37855574-A039607F-9BDD-4120-B6B2-003C1942C5A0Q37925819-ED4C61B2-EF09-4DE2-8DF3-6A0BC67B7043Q38128537-4AACBC06-FC47-4F9D-AB98-74D139D6B419Q39272192-E56B3A87-DA7F-4DEE-BB8A-4773FC24DAD4Q41862354-359BA381-1AB0-41C8-AB7D-A0DCAD45A604Q42185295-B8DA6365-54F0-47C8-A95B-734584181F95Q42589839-0139BD3D-D1CF-413E-999C-208DC846125DQ47191829-6950092D-A0E1-4954-A2B6-9474CE2E19CCQ47611952-A6B15415-A13B-4667-A254-3E4397FC25B6Q50041769-3038D63F-B871-4EDB-8FF0-C00D4740AB0BQ50351086-0A911FBE-0CD2-4AC7-8134-0B766511E3B3Q52688310-C9C712A0-0438-44F7-9A99-E9D0664D5E3FQ55007448-358C9407-BFCE-4E72-A891-8F80A51EF4D8Q55438711-565DBD37-F260-4F20-A3AE-DBBC9188D569
P2860
Cyclic phosphatidic acid - a unique bioactive phospholipid.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cyclic phosphatidic acid - a unique bioactive phospholipid.
@en
type
label
Cyclic phosphatidic acid - a unique bioactive phospholipid.
@en
prefLabel
Cyclic phosphatidic acid - a unique bioactive phospholipid.
@en
P2860
P1476
Cyclic phosphatidic acid - a unique bioactive phospholipid.
@en
P2093
Yuko Fujiwara
P2860
P304
P356
10.1016/J.BBALIP.2008.05.002
P407
P577
2008-05-23T00:00:00Z